1. Medtech Insight
  2. >>Policy & Regulation

23andMe Launches Personal Genome Service For Carrier Screening After Work With FDA

Two years of conversations with FDA have led 23andMe back to the health care market with the Oct. 21 launch of its new Personal Genome Service, focused on carrier screening tests. The firm says its close engagement with FDA has improved its customer communication and quality control.

23andMe Inc.has launched a new direct-to-consumer Personal Genome Service about two years after the company was forced off

the health care market by FDA. The firm says its close engagement with FDA during the interim period has improved...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation